Skip to main content

Dolomite, GigaGen Collaborate on Droplet Merger Chip for Genetic Analysis

NEW YORK (GenomeWeb News) – Dolomite today announced a collaboration with GigaGen to develop a new droplet merger chip for massively parallel single cell genetic analysis.

The two firms also have a licensing deal to offer the technology later this year to academic researchers, as well as commercial scientists.

Financial and other terms were not revealed.

The new glass microfluidic chip enables fast and consistent merging of two individual droplet streams and has applications that include DNA amplification, biochemical analysis, single cell analysis, and high-throughput experimentation, Dolomite said.

The company added that while other methods use "expensive and bulky" high voltage electronics to merge droplets by electrostatic forces, its technology squeezes droplets together in a "carefully designed merging chamber," resulting in a microfluidic device, "which points the way to low cost disposable chips in future versions."

Dolomite designs and develops microfluidic systems and devices and has offices in the US and the UK.

Based in the San Francisco, GigaGen develops genetic-based diagnostics that combines microfluidics, next-generation sequencing, and bioinformatics, according to its website.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.